Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
About the venue
Rooms
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Subscribe
days
hours
minutes
seconds
Policy
Sessions
Wednesday, 23 October
09:00
e-poster session day 1
09:00
to
18:20
Digital kiosks
e-poster session
10:50
Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research
10:50
to
12:20
Auditorium I
Major session
Advancing addiction research: global perspectives and collaborative initiatives
10:50
to
12:20
Auditorium VI
Oral presentation session
Prevalence of opioids and related harms
10:50
to
12:20
Auditorium VIII
Oral presentation session
Support for recovery
10:50
to
12:20
Room 1.07
Short communication session
Alcohol: policy and harm reduction
10:50
to
12:20
Room 1.08
Short communication session
13:20
Enhancing access to harm reduction services in community and prisons: experiences of translating policy into practice and scaling interventions
13:20
to
14:50
Auditorium I
Major session
Drug policy and the criminal legal system
13:20
to
14:50
Auditorium VI
Oral presentation session
Gender and substance use
13:20
to
14:50
Auditorium VIII
Oral presentation session
Substance use interventions in youth
13:20
to
14:50
Room 5A
Oral presentation session
Challenge of measuring use and impact of cannabinoids
13:20
to
14:50
Room 1.07
Oral presentation session
Methods and measurement
13:20
to
14:50
Room 1.08
Short communication session
15:00
Measuring drug market phenomenon
15:00
to
16:30
Auditorium VI
Oral presentation session
The growing threat of synthetic drugs – developments and responses in North America and Europe
15:00
to
16:30
Auditorium VIII
Oral presentation session
Surveillance of drug-related morbidity and mortality
15:00
to
16:30
Room 5A
Oral presentation session
Inequalities and needs of migrant groups
15:00
to
16:30
Room 5C
Oral presentation session
Quality in addictions work systems
15:00
to
16:30
Room 1.06
Oral presentation session
Problematic gambling and gaming
15:00
to
16:30
Room 1.07
Short communication session
16:50
The EUFAS-EAR European Addiction Research Award
16:50
to
18:20
Auditorium I
Major session
Decriminalisation and alternatives to arrest
16:50
to
18:20
Auditorium VI
Oral presentation session
Psychedelics 1
16:50
to
18:20
Auditorium VIII
Oral presentation session
Opioid treatment 1
16:50
to
18:20
Room 5B
Oral presentation session
Hepatitis C, HIV, and other drug related harms
16:50
to
18:20
Room 1.05
Short communication session
Opioids: trends, use and treatments
16:50
to
18:20
Room 1.06
Short communication session
18:30
Why are we not doing better at reducing drug-related deaths?
18:30
to
19:30
Auditorium I
Big debate
Thursday, 24 October
10:50
International collaboration to understand and address the co-occurrence of addiction with ADHD and autism spectrum disorders
10:50
to
12:20
Auditorium I
Major session
Evidence informed drug and alcohol policy
10:50
to
12:20
Auditorium VI
Oral presentation session
Emerging drug harms, DCRs and other responses
10:50
to
12:20
Auditorium VII
Short communication session
Innovative methods for understanding drug markets and policy
10:50
to
12:20
Room 5A
Oral presentation session
Contemporary issues
10:50
to
12:20
Room 1.08
Oral presentation session
13:20
New opportunities for informing clinical practice and policy development in the area of behavioural addictions
13:20
to
14:50
Auditorium I
Major session
Understanding drug-related deaths
13:20
to
14:50
Auditorium IV
Oral presentation session
Conceptual frameworks for studying drug policy
13:20
to
14:50
Auditorium VI
Oral presentation session
Public health and safety impacts of cannabis legalization in Canada: five years in review
13:20
to
14:50
Room 5A
Oral presentation session
European prevention curriculum: increasing the use of evidence-based prevention
13:20
to
14:50
Room 1.06
Short communication session
Women's realities of drug use
13:20
to
14:50
Room 1.08
Oral presentation session
15:00
Alcohol epidemiology: social inequalities
15:00
to
16:30
Auditorium II
Oral presentation session
Hepatitis C testing and treatment
15:00
to
16:30
Auditorium IV
Oral presentation session
Cannabis legalisation — models and impacts
15:00
to
16:30
Auditorium VI
Oral presentation session
Policy issues in gambling
15:00
to
16:30
Room 5B
Oral presentation session
Novel psychoactive substances and latest drug trends in Asia and Pacific countries
15:00
to
16:30
Room 1.05
Oral presentation session
Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain
15:00
to
16:30
Room 1.08
Oral presentation session
16:50
How can the voices of people with lived experience, clients and communities impacted by drug use better inform clinical practice, research and the policy agenda?
16:50
to
17:50
Auditorium I
Big debate
Mixed methods for understanding drug use
16:50
to
18:20
Auditorium III
Oral presentation session
New research on alcohol and tobacco policy
16:50
to
18:20
Room 5A
Oral presentation session
From old to new: changes in drug use
16:50
to
18:20
Room 5C
Oral presentation session
Newly regulated markets, managing harms, treatment & advocating for reform
16:50
to
18:20
Room 1.06
Short communication session
Friday, 25 October
10:50
Gaming and social media use
10:50
to
12:20
Auditorium III
Oral presentation session
Emerging challenges in drug markets: monitoring, measurement & impacts
10:50
to
12:20
Room 1.05
Short communication session
13:20
Alcohol and other drug policies in the work setting – a perspective on European developments
13:20
to
14:50
Auditorium II
Oral presentation session
Young people and drugs
13:20
to
14:50
Auditorium III
Oral presentation session
Addressing diverse treatment needs
13:20
to
14:50
Auditorium VI
Oral presentation session
Regulating cannabis supply policies in Europe: navigating the long road to change
13:20
to
14:50
Auditorium VIII
Oral presentation session
Impact of drug policy on drug production & markets
13:20
to
14:50
Room 5B
Oral presentation session
Future of opioid markets in Europe: Foresight approaches
13:20
to
14:50
Room 1.10
Workshop
Presentations
Wednesday, 23 October
09:00
e-poster
The role of dissociative experiences in the link between psychological distress and Problematic Social Network Sites Use
09:00
to
18:20
Digital kiosks
Simon Ghinassi
e-poster
The Development of an Alcohol Strategy for the Northwest Territories, Canada
09:00
to
18:20
Digital kiosks
Bryany Denning
e-poster
Making Hep C treatment more accessible for addictions patients in Belfast
09:00
to
18:20
Digital kiosks
Andrew Teeney
e-poster
Harm Reduction: A Pathway To Community Health in Nigeria
09:00
to
18:20
Digital kiosks
Fatima Abiola Popoola
e-poster
A business of supplying harm reduction : a necessary evil?
09:00
to
18:20
Digital kiosks
François Destombe
e-poster
Association of Alcohol and Tobacco use on COVID-19 outcomes: A Study from East India
09:00
to
18:20
Digital kiosks
e-poster
A systematic review of second-hand smoking mass media campaigns (2002-2022)
09:00
to
18:20
Digital kiosks
Carmen Lim
e-poster
Risk of relapse to non-opioids among patients treated with XR-NTX or BP-NLX: A randomized clinical trial
09:00
to
18:20
Digital kiosks
Arild Opheim
e-poster
The lived experience of persons receiving harm reduction services, finding an oasis in the deserted life of drug use
09:00
to
18:20
Digital kiosks
Alexandros Tifas
e-poster
Evaluation of participants' experiences enrolled in a community-based mobile withdrawal management service
09:00
to
18:20
Digital kiosks
Andrew Lodge
e-poster
A feasibility and tolerability study of home-use tDCS in patients with substance use disorders (SUD)
09:00
to
18:20
Digital kiosks
Laia Miquel
e-poster
Effectiveness of the brief intervention for methamphetamine users in Poland
09:00
to
18:20
Digital kiosks
Magdalena Rowicka
e-poster
The prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis
09:00
to
18:20
Digital kiosks
Danielle Dawson
e-poster
Is addiction a brain-disease? An overview of the evidence
09:00
to
18:20
Digital kiosks
Chrysanthi Blithikioti
e-poster
Life Entrapment or Trampoline? Understanding life experiences of rejected asylum seekers in Copenhagen’s open drug scene
09:00
to
18:20
Digital kiosks
Arash Setoodeh
e-poster
Tell me who you are, I'll tell you what to do: designing specific interventions for different types of gamers
09:00
to
18:20
Digital kiosks
João Faria
e-poster
Portuguese gym-goers versus Performance-enhancing Substances: What do we know?
09:00
to
18:20
Digital kiosks
Ana Sofia Tavares
e-poster
Offspring of individuals with alcohol use disorders and professionals in addiction counseling: A qualitative study
09:00
to
18:20
Digital kiosks
Fran Calvo
e-poster
Anabolic steroid use and use of other image- and performance-enhancing drugs on the rise – A new substance use disorder
09:00
to
18:20
Digital kiosks
Raphael Magnolini
e-poster
An audit of patient’s Health / Social Care needs referred to a Dual Diagnosis Social Care pathway in Ireland
09:00
to
18:20
Digital kiosks
Aidan Cooney
e-poster
Training Program for Self-management of Substance Addiction Consequences – a Randomized Controlled Trial Pilot Study
09:00
to
18:20
Digital kiosks
Paulo Seabra
e-poster
Are Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study
09:00
to
18:20
Digital kiosks
Said Boujraf
e-poster
Cannabis use and severity of cannabis dependence among Georgian small-scale cannabis growers in 2021
09:00
to
18:20
Digital kiosks
Tamari Mgebrishvili
e-poster
Empowering higher education teachers using tripartite drug awareness training model to support youth well-being
09:00
to
18:20
Digital kiosks
Munir Sewani
e-poster
Exploring the role of gender on treatment outcomes in older adults with alcohol use disorder
09:00
to
18:20
Digital kiosks
Jeppe Tryggedsson
e-poster
Hepatitis C and pharmaceutical multinationals. An approach to the case of Basque Country (Spain) in 2014/2015
09:00
to
18:20
Digital kiosks
Unai Perez de San Roman Landa
e-poster
Exploring Diverse Applications of Multicriteria Decision Analysis in Drug Policy: A Comprehensive Overview.
09:00
to
18:20
Digital kiosks
Nicola Worcman
e-poster
Exploring Cultural Dynamics of Black Asian Ethnic Women in Addiction Recovery
09:00
to
18:20
Digital kiosks
Shinasa Shahid
e-poster
A digital approach to peer led recovery and social connection to address substance use/and or mental health challenges
09:00
to
18:20
Digital kiosks
Susan Barnes
e-poster
Systematic review of recovery of neuropsychological function following abstinence in people with an Alcohol Use Disorder
09:00
to
18:20
Digital kiosks
Anna Powell
e-poster
Evaluation of inpatient conversion from high dose methadone to long-acting injectable buprenorphine (LAIB)
09:00
to
18:20
Digital kiosks
Stuart Fisher
e-poster
The association between psychological distress and alcohol consumption and physical activity
09:00
to
18:20
Digital kiosks
Silvia Eiken Alpers
e-poster
Workforce development and co production as key enablers of successful service delivery.
09:00
to
18:20
Digital kiosks
Martin Blakebrough
e-poster
Degree of smartphone addiction in the university environment
09:00
to
18:20
Digital kiosks
Raul Vernet
e-poster
Personality traits and recovery
09:00
to
18:20
Digital kiosks
Elise Constance Fodstad
e-poster
A narrative review of nurse-led addiction models of care; informing the foundations for international nursing.
09:00
to
18:20
Digital kiosks
Sadie Lavelle Cafferkey
e-poster
Transgender and non-binary people's experiences with alcohol reduction in the UK: A cross-sectional study
09:00
to
18:20
Digital kiosks
Dean Connolly
e-poster
Activities and Experiences of Czech Adolescents in Cyberspace
09:00
to
18:20
Digital kiosks
Martin Dolejš
e-poster
Developing a Toolkit for health care professionals working with Pregnant People who use Drugs in Southern Africa
09:00
to
18:20
Digital kiosks
Julie-Anne Mac Donnell
e-poster
Drug-Facilitated Sexual Assaults involving GHB and GBL in Europe – recent evidence and a need for better monitoring.
09:00
to
18:20
Digital kiosks
María Flores López
e-poster
Systemic biases: Attitudes of correctional staff toward incarcerated people receiving opioid agonist treatment
09:00
to
18:20
Digital kiosks
Joëlle Maguire-L
e-poster
Online gambling and Loneliness: A State of Knowledge.
09:00
to
18:20
Digital kiosks
Volanirina Rasolofomamonjy
e-poster
A Look at Non-Compliance: Examining Alcohol Industry Marketing Practices in Portugal
09:00
to
18:20
Digital kiosks
Hilson Cunha Filho
e-poster
Forgotten children - losses of children growing up with addicted parents
09:00
to
18:20
Digital kiosks
Szilvia Kassai
e-poster
The effects of syringe service programs on overdose deaths in Tennessee
09:00
to
18:20
Digital kiosks
Ryan Edgerton
e-poster
The association between alexithymia and binge drinking among young people
09:00
to
18:20
Digital kiosks
Pelin Alpay
e-poster
Drug checking via Syringe Vending Machines
09:00
to
18:20
Digital kiosks
Mariam Sherozia
e-poster
Alcohol, transitions and communities of belonging within marginalised groups – towards a model of understanding.
09:00
to
18:20
Digital kiosks
Peter Nelson
e-poster
The prevalence of Mental Health Disorders Among Cannabis Users
09:00
to
18:20
Digital kiosks
Ada Hočevar Grom
e-poster
Problematic Mobile Phone Use Related Changes in Topological Organization of Functional Brain Networks
09:00
to
18:20
Digital kiosks
Lichang Yao
e-poster
Comorbid bloodborne diseases among people with opioid use disorders on medication-assisted treatment in Tanzania.
09:00
to
18:20
Digital kiosks
Dorothy Mushi
e-poster
Use of CBD and low-THC products in North Macedonia
09:00
to
18:20
Digital kiosks
Sanja Prosheva
e-poster
Substance Use Treatment for non-speaker of the native language: Implications for migrants and the displaced
09:00
to
18:20
Digital kiosks
Mayar Nawara
e-poster
From intrusive memory to craving in cocaine use disorder – An ecological momentary assessment study
09:00
to
18:20
Digital kiosks
Amelie Zacher
e-poster
Addiction-related dreams: Interpretative Phenomenological Analysis of content and recovery from addiction
09:00
to
18:20
Digital kiosks
Shawn Rutledge
e-poster
Adverse childhood experiences, adult attachment and parenting styles in a population with addictive behaviors
09:00
to
18:20
Digital kiosks
Teodomiro Pires
e-poster
The addiction nursing workforce empowerment - from international perspective to the national implementation and bac
09:00
to
18:20
Digital kiosks
Vendula Pokorná
e-poster
Barriers to Substance Use Treatment as Perceived by Professionals and Arabic Refugees in Germany
09:00
to
18:20
Digital kiosks
Ebtesam Saleh
e-poster
Prevalence of substance use in Austrian prison systems
09:00
to
18:20
Digital kiosks
Andrea Gamper
e-poster
The Moral Improvisation of Harm Reduction in Abstinence Based Drug Policy Amongst Frontline Drug Workers in Hong Kong
09:00
to
18:20
Digital kiosks
Katie Lowe
e-poster
COMPARED RETENTION RATES BETWEEN PATIENTS TREATED WITH BUVIDAL IN FRANCE vs. SUBLINGUAL BUPRENORPHINE (OPALE-2 STUDY)
09:00
to
18:20
Digital kiosks
Alice Deschenau
e-poster
Enhanced Alcohol-Specific Pavlovian-to-Instrumental Transfer in Alcohol Use Disorder
09:00
to
18:20
Digital kiosks
Michael Smolka
e-poster
Implementation of a subject on the care of addiction in the Nursing degree: origin of the need and expectations.
09:00
to
18:20
Digital kiosks
Sheimah El Beijjaji Bouzbita
e-poster
Development of complementary information to drug-related deaths statistics in Slovenia
09:00
to
18:20
Digital kiosks
Mateja Jandl
e-poster
Post-prison support for First Nations men in Australia and Canada
09:00
to
18:20
Digital kiosks
Michael Doyle
e-poster
Framing alcohol policies in non-prohibitionist States: An existentialist dilemma?
09:00
to
18:20
Digital kiosks
Subrata Biswas
e-poster
Cybervictimisation, emotion regulation and family factors in adolescents and young people
09:00
to
18:20
Digital kiosks
e-poster
Resilience and Sense of Coherence as Mediators in the Association between Problematic Mobile Phone Use and Depression
09:00
to
18:20
Digital kiosks
Qi Dai
e-poster
Cannabis use and its link to psychopathological and functional outcomes: Insights from self-reports and hair data
09:00
to
18:20
Digital kiosks
Lydia Johnson-Ferguson
e-poster
People with mental disorders resulting in addiction to alcohol in Poland - legal aspects of medical, social assistance.
09:00
to
18:20
Digital kiosks
Joanna Rajewska de Mezer
e-poster
Integrating Seven Challenges Mastery Counselling and Trauma Informed Care in adolescent substance use interventions.
09:00
to
18:20
Digital kiosks
Daniel Mercieca
e-poster
"Make the difference" - Qualifying professionals working with families with addiction issues
09:00
to
18:20
Digital kiosks
Rebekka Kleinat
e-poster
Electronic cigarettes use among secondary school students in Slovenia
09:00
to
18:20
Digital kiosks
Helena Koprivnikar
e-poster
Implementation of two transdiagnostic psychological interventions for alcohol use: Study protocol, preliminary results
09:00
to
18:20
Digital kiosks
Alba Abanades
e-poster
New criminal legal strategies towards a more effective inmate treatment (The KETHEA PROMITHEAS project)
09:00
to
18:20
Digital kiosks
Apostolos Tsirgoulas
e-poster
Balancing between care and control - staff perception on the introduction of new medication for opioid agonist treatment
09:00
to
18:20
Digital kiosks
Andrea Johansson Capusan
e-poster
ADDIRIS - Addiction and Harm Reduction: a global French-speaking network for online learning
09:00
to
18:20
Digital kiosks
Romain Bach
e-poster
Results of İntegrated Bio-Behavioral surveillance among PWID in Azerbaijan
09:00
to
18:20
Digital kiosks
Gunash Jafarova
e-poster
Burnout and Engagement in Addictive Behaviors and Dependencies HCWs at Portuguese North Region: an epidemiological study
09:00
to
18:20
Digital kiosks
Cátia Coutinho
e-poster
Enrichment of Prevention Methodologies with Self Help/Mutual aid practices: The case of the Centre of Prevention Greece
09:00
to
18:20
Digital kiosks
Sotiris Lainas
e-poster
ComunicAr’te - Communicating through Art in Group Therapy on Addictive Behaviors
09:00
to
18:20
Digital kiosks
Carla Matias
e-poster
Twenty years of integrated treatment of dual disorders in the netherlands: lessons learned
09:00
to
18:20
Digital kiosks
Anneke van Wamel
e-poster
Professional satisfaction and discontent: perspectives of health professionals on Addictive Behaviors and Dependencies
09:00
to
18:20
Digital kiosks
Rita Valinho
e-poster
Evaluation of a UK Bristol capillary blood service for blood-borne virus detection to reach HCV elimination targets
09:00
to
18:20
Digital kiosks
Stephanie Hutchings
e-poster
Prevalence of BBD among PWID in treatment settings in Palestine between 2019-2023
09:00
to
18:20
Digital kiosks
Abeer Habash
e-poster
Social work diagnosis and intervention in a harm reduction service for People Who Use Drugs
09:00
to
18:20
Digital kiosks
Teresa Castro
e-poster
In search of protective factors against burnout in Addictive Behaviors and Dependencies HCWs at Portuguese North Region
09:00
to
18:20
Digital kiosks
Rui Tinoco
e-poster
HCV screening in the treatment centers for people with addictions: lessons learned
09:00
to
18:20
Digital kiosks
Federica Mathis
e-poster
Combination non-medical use of gabapentin and medications for opioid use disorder: A qualitative study
09:00
to
18:20
Digital kiosks
Mance Buttram
e-poster
A National Survey of Alcohol Care Teams (ACTs) in England: Characteristics of Patients and Components of Care
09:00
to
18:20
Digital kiosks
Philippa Case
e-poster
The role of cartoon humor in the context of addictology efforts for the prevention of alcohol and tobacco use
09:00
to
18:20
Digital kiosks
Linda Kočvarová
e-poster
Exploring dual diagnosis in opioid agonist treatment: A comparative study between the Czech Republic and Norway
09:00
to
18:20
Digital kiosks
Svetlana Skurtveit
e-poster
The Value of Outreach (VALOR): An evaluation of the implementation of alcohol assertive outreach in Greater Manchester
09:00
to
18:20
Digital kiosks
Nikolaos Mylonas
e-poster
Crack cocaine use, street life and migrant population. An Italian observatory by ItaRdd, Cnca, Forum Droghe.
09:00
to
18:20
Digital kiosks
Luca Censi
e-poster
Alcohol, Driving and Crime - Health Care and Justice: An Outreach Intervention
09:00
to
18:20
Digital kiosks
Celestino Cunha
e-poster
Buprenorphine prescription patterns at a tertiary care hospital in northern India: A retrospective chart review
09:00
to
18:20
Digital kiosks
Abhishek Gupta
e-poster
Critical assessment of the role of compulsory treatment of drug use disorders in Germany
09:00
to
18:20
Digital kiosks
Ingo Ilja Michels
e-poster
Negative affectivity, mania, and defense mechanisms in compulsive online buying-shopping disorder
09:00
to
18:20
Digital kiosks
Marina Cosenza
e-poster
Gratitude amidst unease: Interviews with Swedish forensic psychiatric male patients with substance use disorder
09:00
to
18:20
Digital kiosks
Charlotta Svensson
e-poster
Mapping drug users’ spaces of fear in Cologne, Germany
09:00
to
18:20
Digital kiosks
Bo Tackenberg
e-poster
Assessing Food Security and Hunger in Heroin-Assisted Treatment (HAT) Participants: Insights from Norway's HAT Project
09:00
to
18:20
Digital kiosks
Omid Dadras
e-poster
Pilot implementation of a drug overdose reporting tool among Texas harm reduction organizations: A mixed methods study
09:00
to
18:20
Digital kiosks
Jake Samora
e-poster
Working memory in context: the role of alcohol distractors in low to heavy alcohol drinkers
09:00
to
18:20
Digital kiosks
Karis Colyer-Patel
e-poster
Contribution of the workforce to retention of clients in Kombani Medically Assisted Therapy (MAT) in Kwale, Kenya.
09:00
to
18:20
Digital kiosks
Esther Mumo
e-poster
Hospitalizations due to the use of psychoactive substances in Portugal: Impact assessment of the 2008 economic crisis
09:00
to
18:20
Digital kiosks
Joana Silva
e-poster
Exploring the gendered impact on women of the impact of the changes in commissioning in drug and alcohol services.
09:00
to
18:20
Digital kiosks
Victoria Beere
e-poster
Using a digital client segmentation tool among clients with problematic substance use
09:00
to
18:20
Digital kiosks
Ella Plaami
e-poster
Chemsex: An Umbrella Review
09:00
to
18:20
Digital kiosks
Liam Johnstone
e-poster
Mania a Potu: Review of the literature
09:00
to
18:20
Digital kiosks
Ines Valada
e-poster
Challenges and needs of Cologne's open drug scene: insights from a quantitative study on Neumarkt square
09:00
to
18:20
Digital kiosks
Daniel Deimel
e-poster
Medicinal use of non-prescribed cannabis: motives for use, perceived effectiveness and barriers to treatment (MEDUSA)
09:00
to
18:20
Digital kiosks
Lisa Strada
e-poster
Improving the diagnosis and clinical outcomes on drug addict patients through quantitative spectrometer testing.
09:00
to
18:20
Digital kiosks
Teodora Ciolompea
e-poster
DCR in Paris : a constant experiment
09:00
to
18:20
Digital kiosks
Victor Detrez
e-poster
The Intersection of Gambling with Smoking and Alcohol use in Great Britain: A Cross-Sectional Survey in October 2022
09:00
to
18:20
Digital kiosks
Loren Kock
e-poster
Identification and treatment of alcohol use disorder with the 15-method – implementation in psychiatric care
09:00
to
18:20
Digital kiosks
Jennie Sundbye
e-poster
Benefits of a Yoga intervention in portuguese female inmates: preliminary results
09:00
to
18:20
Digital kiosks
Andreia Nisa
e-poster
Long-Term Outcomes of Substance Use Treatment: A 20-Year Follow-Up Study in the Swedish Addiction Treatment System
09:00
to
18:20
Digital kiosks
Tove Sohlberg
e-poster
Doping Prevention among Recreational Athletes and the Role of the Police
09:00
to
18:20
Digital kiosks
Tobias Elgán
e-poster
Mortality Rates and cause-specific mortality in Patients with Substance-Induced Psychosis
09:00
to
18:20
Digital kiosks
Pihla Sassi
e-poster
Psychological Phenotypes in Glambling Disorder: A case study using the Pathway Model
09:00
to
18:20
Digital kiosks
Ana Llorente
e-poster
Trilhos - Evaluation of a developmental prevention program
09:00
to
18:20
Digital kiosks
Inês Abraão
e-poster
Developing practical tools for identifying and supporting treatment-relevant cognitive dys/functions
09:00
to
18:20
Digital kiosks
Maria Bravo Aguilera
e-poster
The potential of eHealth in the treatment of substance use disorders: a perspcitive on digital theraies
09:00
to
18:20
Digital kiosks
André Almeida
e-poster
Scottish stakeholder views on closing the evidence to practice gap in substance use prevention
09:00
to
18:20
Digital kiosks
Tara Shivaji
e-poster
Impact of Adherence to the Opioid Substitution Program on Social Determinants of Health in the West Zone of Porto
09:00
to
18:20
Digital kiosks
Isabel Ponte
e-poster
Inpatient ketamine detoxification, characterization of a treatment-seeking population with complex needs
09:00
to
18:20
Digital kiosks
Osunwale Oni
e-poster
Effects of oxytocin and nicotine addiction on psychosocial stress: an fMRI study
09:00
to
18:20
Digital kiosks
Jiecheng Ren
e-poster
Catalysts for Change: Youth-Driven Insights in Opioid Harm Reduction
09:00
to
18:20
Digital kiosks
Rebeca Calzada
e-poster
"Pictures (and Drugs) at an exibition"
09:00
to
18:20
Digital kiosks
Patrizio Lamonaca
e-poster
Prevention of FASD in Luxembourg – a status report
09:00
to
18:20
Digital kiosks
Jonathan Uselding
e-poster
The role of COVID-19 in sleep quality and cognitive performance in alcohol–dependent patients
09:00
to
18:20
Digital kiosks
Lea Kozina
e-poster
Psychosocial and financial vulnerabilities in loot box purchasing: The mediating role of problem gambling
09:00
to
18:20
Digital kiosks
Anu Sirola
e-poster
Psychological factors associated to problematic gambling in university students from Lima, Perú.
09:00
to
18:20
Digital kiosks
e-poster
OUTCAST REGISTRATION: an archive of imprisoned female drug users' biographies
09:00
to
18:20
Digital kiosks
Ulrike Möntmann
e-poster
Electroencephalographic indices of stages of reward memory and implications for therapeutic memory reconsolidation
09:00
to
18:20
Digital kiosks
Shelan Ofori
e-poster
HIV among people who inject drugs in Stockholm - prevalence, incidence and treatment outcomes
09:00
to
18:20
Digital kiosks
Martin Kåberg
e-poster
Self-inflicted cut throat injuries and substance use during COVID-19: An analysis from Nepal
09:00
to
18:20
Digital kiosks
Dipesh Bhattarai
e-poster
Role of Psychiatric Nursing Staff in a Newly Founded Ward for Treatment of Adolescents Facing Addiction
09:00
to
18:20
Digital kiosks
Aleš Zajc
e-poster
Long-term Effects of the STAD-model: A Multi-Component Responsible Beverage Service Intervention
09:00
to
18:20
Digital kiosks
Johanna Gripenberg
e-poster
Therapeutic Effects of Ayahuasca: The Psychological Processes Involved in the Relief of Depression and Grief.
09:00
to
18:20
Digital kiosks
Mafalda Pinto Ribeiro
e-poster
Threat or opportunity: End-user perspectives on digital interventions for treatment of cannabis use
09:00
to
18:20
Digital kiosks
Jasmin Lostedt
e-poster
Gender violence experienced by women who use drugs
09:00
to
18:20
Digital kiosks
Ana Isabel Ibar-Fañanás
e-poster
Psychosocial Factors Affecting Drug Relapse Among Youth in Pakistan
09:00
to
18:20
Digital kiosks
Abdul Waheed Tabish
e-poster
COVID-19 and earthquakes-related stress, quality of life, mental health, and internet-based addictive behaviour
09:00
to
18:20
Digital kiosks
Tina Peraica
e-poster
Process indicators and outcomes of patients with SUD and Emotional Disorders: Comparison of pre-post COVID-19 pandemic
09:00
to
18:20
Digital kiosks
Oscar M. Lozano
e-poster
An evaluation of “harm reduction” outreach service evaluative research in Macau
09:00
to
18:20
Digital kiosks
Augusto Nogueira
e-poster
Smoking among people who use drugs
09:00
to
18:20
Digital kiosks
Ingeborg Lund
e-poster
Conceptual competence in addiction: integrative contributions from philosophical and theoretical work in psychiatry
09:00
to
18:20
Digital kiosks
Carl Erik Fisher
e-poster
Reitox National Focal Point Drug Monitoring System as a Model for Monitoring Other Addictions in Czechia
09:00
to
18:20
Digital kiosks
Pavla Chomynova
e-poster
Characterising South Africa’s drug markets with people who sell heroin, methamphetamine and cocaine
09:00
to
18:20
Digital kiosks
MJ Stowe
e-poster
Assessing hindering and facilitating factors of help-seeking behaviour in cannabis use: descriptive qualitative study
09:00
to
18:20
Digital kiosks
Laura Väätäinen
e-poster
SCIRe: Substance Consumption Informative Research - testing hair in electronic music festivals
09:00
to
18:20
Digital kiosks
Ana Pego
e-poster
Recreational substance use and cognition in a large cohort of young adults with hair testing: Something is not nothing
09:00
to
18:20
Digital kiosks
Lukas Eggenberger
e-poster
Smartphone addiction and sexual distress: preliminary findings of a study in Portugal
09:00
to
18:20
Digital kiosks
Pedro Campos
e-poster
Neurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence
09:00
to
18:20
Digital kiosks
Elena Psederska
e-poster
Italian teenagers’ perceived exposure to Digital Alcohol Marketing
09:00
to
18:20
Digital kiosks
Franca Beccaria
e-poster
No alcohol at night – Polish experiences
09:00
to
18:20
Digital kiosks
Marta Zin-Sedek
e-poster
When substance use disorder and eating disorder intersect: an integrated care tool.
09:00
to
18:20
Digital kiosks
Zoya Barbier
e-poster
The role of temperamental self-regulation in predicting treatment outcome in alcohol use disorders
09:00
to
18:20
Digital kiosks
Els Santens
e-poster
Ethical considerations of responsible gambling in metaverse
09:00
to
18:20
Digital kiosks
Susanne Uusitalo
e-poster
Alcohol guidelines in Australia - who knows them?
09:00
to
18:20
Digital kiosks
e-poster
Love Addiction: Trait Impulsivity, Emotional Dysregulation and Attachment Style
09:00
to
18:20
Digital kiosks
Jessica Dineen
e-poster
TREATMENT PROGRAMS FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH MENTAL AND BEHAVIORAL DISORDERS DUE TO PAS USE
09:00
to
18:20
Digital kiosks
Andrej Kastelic
e-poster
Using Functional Near Infrared Spectroscopy to Detect Neurocognitive Differences Across Social Drinking Patterns
09:00
to
18:20
Digital kiosks
Rebecca Kuiper
e-poster
Global trends and Challenges of the Drug Phenomenon in Central Asia
09:00
to
18:20
Digital kiosks
Ernest Robello
e-poster
Online gambling and betting in India and their adverse psychological and social complications: A comprehensive review
09:00
to
18:20
Digital kiosks
Shyam Sundar Kanagarajan
e-poster
Psychosocial Determinants of Cannabis Protective Behavioral Strategies: Perceived Efficacy and Social Norms
09:00
to
18:20
Digital kiosks
Fermin Fernández Calderón
e-poster
Nightlife recreational contexts in Viseu: sexism, sexual violence and potential associations with substance use
09:00
to
18:20
Digital kiosks
Inês Miguel Rodrigues Armelim
e-poster
Impact of fruit smoothie supplementation on psychological distress in patients undergoing opioid agonist therapy
09:00
to
18:20
Digital kiosks
Elaheh Javadi Arjmand
e-poster
Frequency of cannabis and amphetamine use past month in patients on opioid maintenance treatment with buprenorphine
09:00
to
18:20
Digital kiosks
Natasha Simonovska
e-poster
Generative AI to support Harm Reduction
09:00
to
18:20
Digital kiosks
Angus Bancroft
e-poster
30 years of New Psychoactive Substances (NPS) in Europe. A first integrated public health assessment.
09:00
to
18:20
Digital kiosks
Julian Vicente
e-poster
Comparison of HOMA-IR, Tg/Glucose Index and Tg/HDL-C ratio for predicating MetSy in HCV seronegative heroin dependents
09:00
to
18:20
Digital kiosks
Zanina Perevska
e-poster
Rhabdomyolysis in patients following opioid overdose
09:00
to
18:20
Digital kiosks
Aleksandra Babulovska
e-poster
Common mental disorders in prisoners with childhood trauma and substance use; the role of emotion regulation
09:00
to
18:20
Digital kiosks
Faridah Nakoma
e-poster
Program evaluation of a team-based approach addressing mental health and addictions in a Canadian urban centre
09:00
to
18:20
Digital kiosks
Andrew Lodge
e-poster
Public Health addressing illicit drug use and mental health disorders: Interinstitutional Community Intervention Group
09:00
to
18:20
Digital kiosks
Paula Pinto Oliveira
e-poster
Investigating the Relationship Between Stigma and Relapse in IDUs with HIV/AIDS in Pakistan
09:00
to
18:20
Digital kiosks
Jawwad Muhammad Shujaat
e-poster
If you don't know where you're going, why insist on running - A reflection on the lack of data on dropout...
09:00
to
18:20
Digital kiosks
Sofia Freitas
e-poster
Features and correlates of Internet Gaming Disorder in women and men who play video games: a cross-national study
09:00
to
18:20
Digital kiosks
Caitlin McClure-Thomas
e-poster
Challenges in the management of skin and soft tissue infections among people who inject drugs in Athens, Greece.
09:00
to
18:20
Digital kiosks
Apostolia Fragkouli
e-poster
Association between slot machine gambling and debt recovery process-Finnish population-based study with register linkage
09:00
to
18:20
Digital kiosks
Tiina Latvala
e-poster
The recovery of people with addictive behaviours and dependencies: intervention strategies of social workers
09:00
to
18:20
Digital kiosks
Sara Carvalho
e-poster
High and repeated use of MDPV induce chronic psychosis in patients with no psychiatric history
09:00
to
18:20
Digital kiosks
Andrea Anastasi
e-poster
A Prospective Study: Patterns and Trends in Opioid Use and Treatment with Focus on Older Populations
09:00
to
18:20
Digital kiosks
Jo-Hanna Ivers
e-poster
Suicidal Behaviors and Alcohol Dependence: A Comprehensive Literature Review
09:00
to
18:20
Digital kiosks
Marco Mota Oliveira
e-poster
Assessing progress towards viral hepatitis B and C elimination in prison settings in the European region
09:00
to
18:20
Digital kiosks
Riccardo Pisetta
e-poster
Experiences with Xylazine among Residential Treatment Patients
09:00
to
18:20
Digital kiosks
Courtney Nordeck
e-poster
The role of coping in the association between cannabis use disorder and mental health; a one-year prospective study
09:00
to
18:20
Digital kiosks
Nora de Bode
e-poster
Analysis of the satisfaction survey results of users of the Mobile Drug Consumption Room Program in Lisbon
09:00
to
18:20
Digital kiosks
Adriana Almeida
e-poster
Community led networking and advocacy for the elimination of discrimination of women who use drugs in Europe
09:00
to
18:20
Digital kiosks
Ligia Parodi
e-poster
Experiences of female substance users with trauma-sensitive yoga as complementary support in addiction treatment
09:00
to
18:20
Digital kiosks
Julie Schamp
e-poster
Efficacy of a digital intervention to reduce or stop cannabis use : study protocol for a randomized controlled trial
09:00
to
18:20
Digital kiosks
Emmanuel Lahaie
e-poster
Self-rated health among patients in opioid agonist therapy
09:00
to
18:20
Digital kiosks
Jan Tore Daltveit
e-poster
Impact of first cardiovascular event versus consecutive episodes on tobacco and alcohol use: a comprehensive analysis
09:00
to
18:20
Digital kiosks
Maria Teresa Pons
e-poster
Navigating cannabis access in zurich: A road safety perspective from early observations of the 'Züri Can' study
09:00
to
18:20
Digital kiosks
Patricia Dürler
e-poster
The impact of the tobacco law on hospitalizations due to the abusive consumption of psychoactive substances
09:00
to
18:20
Digital kiosks
Filipe Pinto
e-poster
Anxiety, Depression, Stress, and Self-Harm in relation to Gaming Disorder: A Longitudinal Study of Czech Adolescents
09:00
to
18:20
Digital kiosks
Jaroslava Suchá
e-poster
Complicated Alcohol Withdrawal Syndrome: retrospective study of an inpatient alcohol treatment unit
09:00
to
18:20
Digital kiosks
Ines Pereira
e-poster
Addiction, a volitional disorder.
09:00
to
18:20
Digital kiosks
Nicolas Figueired
e-poster
Oniomania: a case study according to the differential diagnosis
09:00
to
18:20
Digital kiosks
Sofia Nunes
e-poster
Advancing Addiction Interventions: Porto's Comprehensive Approach in the Municipal Health Plan
09:00
to
18:20
Digital kiosks
Paula Pinto Oliveira
e-poster
"Supersavers" manages large proportion of opioid overdoses – 5-year follow-up of a regional naloxone program, Sweden
09:00
to
18:20
Digital kiosks
Katja Troberg
e-poster
Mapping psychedelic retreats and other practices in the EU
09:00
to
18:20
Digital kiosks
Tereza Černíková
e-poster
Oniomania: what is known today?
09:00
to
18:20
Digital kiosks
Margarida Duarte
e-poster
Ageing in the context of the Opioid Maintenance Treatment in Portugal: Impact of public health policies on ageing users
09:00
to
18:20
Digital kiosks
Lara Queiroz Sampaio
e-poster
Recreational Cannabis and Social Media Use: A Correlational Cross-Sectional Study
09:00
to
18:20
Digital kiosks
Roni Deli-Houssein
e-poster
Psilocin inhibits CYP450 metabolism of isoforms 2A6 and 3A4
09:00
to
18:20
Digital kiosks
Andreia Machado Brito-da-Costa
e-poster
"How generational transmissions can shape life?" Evaluation of a genogram group therapy for people with ACoA syndrome
09:00
to
18:20
Digital kiosks
Katarzyna Iwanicka
e-poster
Piloting a strategy to prevent and manage alcohol-related problems in underage population at risk in health services
09:00
to
18:20
Digital kiosks
Carla Filipa Bruguera
e-poster
Burden of disease due to drug use disorders in the European Union: analysis of 1990-2019 trends and patterns
09:00
to
18:20
Digital kiosks
Vera Pinheiro
e-poster
Willingness and Contextual Considerations for Supervised Consumption Sites among People Who Inject Drugs in Stockholm
09:00
to
18:20
Digital kiosks
Elin Holmén
e-poster
LGBTQIA2S+ perspectives on problem gambling among their peers: Preliminary results of semi-structured interviews
09:00
to
18:20
Digital kiosks
Anne-Marie Auger
e-poster
DUDIT-E Brazilian Adaptation and TrIE-AD Application Development: A Intervention Approach for Young Drug Users
09:00
to
18:20
Digital kiosks
Richard Alecsander Reichert
e-poster
Riscos & Desafios Program: the students’ voice
09:00
to
18:20
Digital kiosks
Gizela Rendo
e-poster
THE ROLE OF WORK IN THE TREATMENT OF INDIVIDUALS RECOVERING FROM ADDICTION
09:00
to
18:20
Digital kiosks
Farshad moshiri
e-poster
Changes in self-reported alcohol use post absolute alcohol sales bans: the case of Botswana during COVID pandemic.
09:00
to
18:20
Digital kiosks
J. Maphisa Maphisa
e-poster
Understanding Overdose Risk Perception in People who use Drugs - A Systematic Review
09:00
to
18:20
Digital kiosks
Kerry B.D. Campbell
e-poster
Effects of a universal school based alcohol prevention intervention
09:00
to
18:20
Digital kiosks
Bert Hauspie
e-poster
Risky online behavior in relation to social support, depression and anxiety in Czech adolescents
09:00
to
18:20
Digital kiosks
Terezie Babilonová
e-poster
Veterinary Drugs as Toxic Adulterating Substances in the Street Drug Supply
09:00
to
18:20
Digital kiosks
Barry Logan
e-poster
IN VITRO INHIBITORY POTENTIAL OF CLASSIC HALLUCINOGENS LSD, 5-MEO-DMT AND MESCALINE OVER CYTOCHROME P450 ENZYMES
09:00
to
18:20
Digital kiosks
Mariana Carvalho
e-poster
Working Towards Health and Wellness: The Infinite Pathways of Recovery
09:00
to
18:20
Digital kiosks
Meghann Perry
e-poster
Can we prevent the misuse of prescription stimulants? : a case report
09:00
to
18:20
Digital kiosks
Ivana Todorić Laidlaw
e-poster
Risks and challenges of scaling up the intervention – an analysis of the program dissemination process
09:00
to
18:20
Digital kiosks
Carla Rocha
e-poster
Lived/Living experiences: the potential for integrative collaborations
09:00
to
18:20
Digital kiosks
Mary Beth Zeni
e-poster
Applying foresight research for drug policy: Lessons from the DRUG-PREP project
09:00
to
18:20
Digital kiosks
Bert Hauspie
e-poster
Estimation of prevalence (and patterns) of cannabis use from various data sources
09:00
to
18:20
Digital kiosks
Darja Lavtar
e-poster
Providing psychiatric services for hepatitis C virus patients with substance use disorders
09:00
to
18:20
Digital kiosks
Anna Gorodetsky
e-poster
Acute and Chronic Effects of Cannabis on the Neural Correlates of Working Memory in Adolescents versus Adults
09:00
to
18:20
Digital kiosks
Sorcha Hamilton
e-poster
The future of smoking is female: Barriers for women to quit. A review.
09:00
to
18:20
Digital kiosks
e-poster
Adherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine
09:00
to
18:20
Digital kiosks
Michael Frost
e-poster
Case Series: Prospective Study on the Efficacy of Pregabalin in Managing Opioid Withdrawal Syndrome
09:00
to
18:20
Digital kiosks
Sofia Golbreich
e-poster
Is Integrating Online Stop Smoking Support to Existing Online Talking Therapy Support Feasible?
09:00
to
18:20
Digital kiosks
Pamela Jacobsen
e-poster
Is Decriminalising drugs enough? Navigating alternatives to prohibitionism
09:00
to
18:20
Digital kiosks
Jorge Quintas
e-poster
Leveraging AI to supercharge the training and support of extended workforce in addiction services
09:00
to
18:20
Digital kiosks
Christina Todorova
e-poster
Shaping a model for Incentivised Drug Free Living wings in prison
09:00
to
18:20
Digital kiosks
e-poster
Trust in healthcare providers for information about cannabis
09:00
to
18:20
Digital kiosks
Meredith Meacham
e-poster
Stigma and substance use disorders: a scoping review of patient and health care professionals’ attitudes.
09:00
to
18:20
Digital kiosks
Ashlyn Schwartz
e-poster
The necessary adaptation of a public Therapeutic Community to new needs of the treatment process.
09:00
to
18:20
Digital kiosks
Rita Fazenda Vieira
e-poster
Cannabis use and withdrawal and escalation to psychiatric intensive care
09:00
to
18:20
Digital kiosks
Edward Chesney
e-poster
“To smoke feels gender”: A Photovoice Study of Cannabis Use Among Transgender and Non-Binary Youth
09:00
to
18:20
Digital kiosks
Christian Barborini
e-poster
The effect of Cue-induced Retrieval and Reconsolidation with Episodic Foresight on craving in opioid users receiving MMT
09:00
to
18:20
Digital kiosks
Parnian Rafei
e-poster
Cannabis legalization in Germany: Update on an ongoing process
09:00
to
18:20
Digital kiosks
e-poster
Sleep dysregulation in alcohol use disorders. An exploratory study with a gender perspective.
09:00
to
18:20
Digital kiosks
Ana Llorente
e-poster
Voices of the unhoused from Santa Fe, New Mexico: health status, substance use, and community harm reduction views
09:00
to
18:20
Digital kiosks
Laura Brown
e-poster
The Last Decade in Turkish Addiction Research: A Thesis-Based Analysis
09:00
to
18:20
Digital kiosks
Belgin Varol
e-poster
Fentanyl among adolescent in Poland - the scale of the phenomenon and preventive actions
09:00
to
18:20
Digital kiosks
Ewelina Silecka-Marek
e-poster
The comparison and analysis of blood antioxidant levels in alcohol and drug addiction
09:00
to
18:20
Digital kiosks
Nelly Sapojnikova
e-poster
Stigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes
09:00
to
18:20
Digital kiosks
Theresa Caruana
e-poster
Cortical thickness and brain aging in individuals engaging in unhealthy alcohol use
09:00
to
18:20
Digital kiosks
Marco Hermesdorf
e-poster
Alcohol use across trials of psychological interventions for bipolar: A systematic review and meta-analysis
09:00
to
18:20
Digital kiosks
Lauren Halsall
e-poster
Optimizing Overdose Response in the Emergency Department: New challenges and initiatives in Scotland
09:00
to
18:20
Digital kiosks
Lisa Schölin
e-poster
Hybrid skills transfer of the unplugged prevention programme in a French high school abroad (Lisbon, Portugal 2023 2024)
09:00
to
18:20
Digital kiosks
Marion Fal
e-poster
Applied health research in alcohol-related liver disease: a rapid qualitative inquiry with healthcare providers
09:00
to
18:20
Digital kiosks
Sofia Hemrage
e-poster
Caring with Care: VITAE’s integrative and therapeutic model towards socially vulnerable individuals
09:00
to
18:20
Digital kiosks
Brenda Sousa da Silva
e-poster
Addictive Behaviours Workforce development: from global to European higher education programs
09:00
to
18:20
Digital kiosks
Olatz López Fernández
e-poster
Substance Use Among College Students in India: Necessity for Intervention
09:00
to
18:20
Digital kiosks
Anju Dhawan
e-poster
Meaning and Self-control in Alcohol Use and Internalizing Symptoms: Causal Insights from (Non)clinical Populations
09:00
to
18:20
Digital kiosks
Marcel Näther
e-poster
Italian Validation of Assessment of Recovery Capital Scale in Clinical Population with Alcohol and Drugs Use Disorder
09:00
to
18:20
Digital kiosks
Teo Vignoli
e-poster
Building Capacity for Social Return on Investment Analysis of Supervised Consumption Services in Saskatoon SK, Canada
09:00
to
18:20
Digital kiosks
Barbara Fornssler
e-poster
Intervention methods for the psychological problems faced by the wives of individuals with substance use disorders.
09:00
to
18:20
Digital kiosks
Ranasinghe Mudiyanselage Sanjeewani Senevirathne
e-poster
Systematic analysis of Interventions for Opioid Use Disorder Among Adolescents
09:00
to
18:20
Digital kiosks
Joye Anestis
e-poster
Perceptions of alcohol-related problems among social workers and their clients
09:00
to
18:20
Digital kiosks
e-poster
The prevalence, risk and protective factors of the co-morbidity of neurodiversity and substance use.
09:00
to
18:20
Digital kiosks
Catherine Comiskey
e-poster
SCHEMATIC FUNCTIONING AND EMOTIONAL REGULATION IN ALCOHOL DEPENDENCE: A CLINICAL AND NON-CLINICAL SAMPLE COMPARISON
09:00
to
18:20
Digital kiosks
Ana Catarina Nunes da Silva
e-poster
Unmasking addictions: exploring the role of attributional styles
09:00
to
18:20
Digital kiosks
Ana Tavares
e-poster
Prevention Matters: Towards a National Model of Prevention (within the National Programme on Illicit Drugs 2023 - 2030)
09:00
to
18:20
Digital kiosks
Mateja Markl
e-poster
Assessing Therapeutic Alliance: A Pilot Study Measuring Therapeutic Alliance and It's Impact on Patient Outcomes
09:00
to
18:20
Digital kiosks
Siobhan Morse
e-poster
The Impact of psychotherapy on Comorbid Borderline Personality Disorder and Substance Use Disorder: A Systematic Review
09:00
to
18:20
Digital kiosks
Manuel Jesús Ruiz Muñoz
e-poster
The Autonomic Craving Signature: a biomarker of craving for personalized addiction treatment
09:00
to
18:20
Digital kiosks
Marc Auriacombe
e-poster
Enhancing HIV Self-Testing Uptake through Syringe Vending Machines: A Case Study in Tbilisi, Georgia
09:00
to
18:20
Digital kiosks
Irma Kirtadze
e-poster
Therapy of alcohol-dependent women serving prison sentences in Polish prisons
09:00
to
18:20
Digital kiosks
Hanna Karaszewska
e-poster
Image and performance enhancing drugs among gym and fitness visitors in Slovenia – preliminary results
09:00
to
18:20
Digital kiosks
Julijana Zucchiati Godina
e-poster
Assessing the prevalence of problem gambling among the Slovenian population
09:00
to
18:20
Digital kiosks
Špela Selak
e-poster
Investigating the relationship between defense styles and treatment motivation of Turkish males with alcohol use problem
09:00
to
18:20
Digital kiosks
Fatmatüz Zehra Pehlivan
e-poster
Packaging of disposable vaping products and e-liquids in England, Canada, and the United States: a content analysis
09:00
to
18:20
Digital kiosks
Matilda Nottage
e-poster
The effect of smoking cessation interventions on socioeconomic inequalities in smoking: A Cochrane systematic review
09:00
to
18:20
Digital kiosks
Annika Theodoulou
e-poster
Drug-Related Deaths following Bariatric surgery: Case Series Report
09:00
to
18:20
Digital kiosks
Eman Mshari
e-poster
Spanish version of the Bergen Social Media Addiction Scale (BSMAS): validity, reliability and measurement invariance
09:00
to
18:20
Digital kiosks
Conchita Sisi Martin
e-poster
Impact of the Decriminalization on Drug Use Experiences and Related Risks among People Who Use Drugs in British Columbia
09:00
to
18:20
Digital kiosks
Cayley Russell
e-poster
Opiate-Dependent Service Users knowledge and attitudes towards Supervised Injecting Facilities
09:00
to
18:20
Digital kiosks
Annika Gibbons
10:50
Discussion
Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research
10:50
to
12:20
Auditorium I
Rosalie Liccardo Pacula,
Susan Weiss ,
Hanan Abramovici,
Beau Kilmer,
François Gagnon
Oral presentation
NIDA International Program Research Update
10:50
to
12:20
Auditorium VI
Tom Clarke
Oral presentation
Understanding the research capacity of Australian alcohol and other drug services
10:50
to
12:20
Auditorium VI
Robert Stirling
Oral presentation
World Addiction Medicine Reports: International Society of Addiction Medicine Global Expert Network Global Surveys
10:50
to
12:20
Auditorium VI
Oral presentation
Report from LX24 side event - Strengthening networks and sharing innovation in practices on research and surveillance in the drugs field
10:50
to
12:20
Auditorium VI
Vickna Kasinather,
Charles Parry
Oral presentation
EUDA research model
10:50
to
12:20
Auditorium VI
Maria Moreira
Oral presentation
Modelling the wider socio-economic costs of problematic opioid use in the UK
10:50
to
12:20
Auditorium VIII
George Keel
Oral presentation
Twenty-one years of heroin-related mortality in Australia: Joinpoint regression analysis of trends by age and gender
10:50
to
12:20
Auditorium VIII
Amanda Roxburgh
Oral presentation
Underestimate of deaths due to specific opioids in England and Wales for a decade
10:50
to
12:20
Auditorium VIII
Shuoqi Chen
Oral presentation
Prevalence of opioid dependence in Scotland, 2015-2020: results from a Multi Parameter Estimation of Prevalence model
10:50
to
12:20
Auditorium VIII
Hayley Jones
Short communication
A systematic review of the nuances of attachment, bonding and parenting for mothers in addiction recovery
10:50
to
12:20
Room 1.07
Louise McCulloch
Short communication
The role of specialist substance use and addiction treatment in building recovery capital
10:50
to
12:20
Room 1.07
Florian De Meyer
Short communication
Recovery does not stop at discharge: A qualitative evaluation of Alcohol Recovery Navigators in North East England.
10:50
to
12:20
Room 1.07
Emma-Joy Holland
Short communication
Exploring Personal Strengths and Resources in Long-Term Substance Use Disorder Recovery: Insights from Lived Experience
10:50
to
12:20
Room 1.07
Myriam Beaulieu
Short communication
The effect of Individual Placement and Support on employment outcomes for individuals with substance use disorders
10:50
to
12:20
Room 1.07
Eline Borger Rognli
Short communication
Understanding the process of drug addiction recovery through learning from lived experience
10:50
to
12:20
Room 1.07
Thomas Martinelli
Short communication
Emotional dysregulation as a predictor of cocaine severity and withdrawal symptoms
10:50
to
12:20
Room 1.07
Alba Palazón-Llecha
Short communication
“I drink less and that's no small matter”: A qualitative study of a managed alcohol program evaluation in Barcelona.
10:50
to
12:20
Room 1.08
Amaia Garrido
Short communication
Barriers for treatment in alcohol use disorders (AUD) – the role of stigmatization: A consumer’s perspective
10:50
to
12:20
Room 1.08
Anja Bischof
Short communication
Corporate political activities of the Portuguese Alcohol Industry post-COVID-19, where do we stand?
10:50
to
12:20
Room 1.08
Francisca Pulido Valente
Short communication
A Longitudinal Evaluation of an Alcohol Related Brain Injury Specialist Residential Rehabilitation Service
10:50
to
12:20
Room 1.08
Anne Campbell
Short communication
Pragmatic case finding as a strategy to improve addressing alcohol in general practice – a mixed methods pilot study
10:50
to
12:20
Room 1.08
Torgeir Gilje Lid
Short communication
An Alcohol Strategy for the Northwest Territories
10:50
to
12:20
Room 1.08
Bryany Denning
Short communication
The problematisation of alcohol in the Northern Territory: what did Alcohol Mandatory Treatment seek to address?
10:50
to
12:20
Room 1.08
Sarah Clifford
Short communication
Embodied Storytelling: An Accessible Approach to Re-storying in the Recovery Process
10:50
to
12:20
Room 1.07
Meghann Perry
Short communication
Religious and community leaders role in addressing alcohol and other drug harms in CALD communities
10:50
to
12:20
Room 1.08
Short communication
Managed Alcohol Programmes: a realist review to identify what works, for whom, and in what circumstance
10:50
to
12:20
Room 1.08
Emma King
13:20
Keynote presentation
Enhancing scale-up of needle and syringe programs in the community in Sweden
13:20
to
14:50
Auditorium I
Martin Kåberg
Keynote presentation
Achieving high-coverage and retention in opioid agonist treatment in the community in Spain
13:20
to
14:50
Auditorium I
Francina Fonseca
Oral presentation
Why is a gender perspective needed in the drug field? Insight from the latest European drugs data.
13:20
to
14:50
Auditorium VIII
Linda Montanari
Keynote presentation
Introduction and expansion of needle and syringe programs and opioid agonist treatment in prison in Moldova
13:20
to
14:50
Auditorium I
Svetlana Doltu
Keynote presentation
Overdose prevention site development and delivery in Switzerland
13:20
to
14:50
Auditorium I
Florian Meyer
Discussion
How do we optimise and integrate the provision of harm reduction services in the community and prison?
13:20
to
14:50
Auditorium I
Julia Sheehan,
Martin Kåberg,
Francina Fonseca,
Svetlana Doltu,
Florian Meyer
Oral presentation
Bridging the Gap: Exploring School Survey Data in Drug Policy and Prevention - Insights from the ESPAD-MedSPAD Project
13:20
to
14:50
Room 5A
Elisa Benedetti
Oral presentation
Cultural adaptations in adolescent prevention programs: a scoping review on substance use and mental health.
13:20
to
14:50
Room 5A
Oral presentation
Developing and operationalising a multi-component drug outreach service for young people aged 16-25 in England
13:20
to
14:50
Room 5A
Zoe Welch
Oral presentation
Risk factors for the gambling, smoking and alcohol consumption triad: an observational study in Portuguese adolescents
13:20
to
14:50
Room 5A
Pedro Ramos
Oral presentation
Global coverage of interventions to prevent and manage injecting drug use related harms in prisons: a systematic review
13:20
to
14:50
Auditorium VI
Thomas Santo Jr.
Oral presentation
Drug-induced homicide laws in the US: current trends, stakeholder opinions, and public health impacts
13:20
to
14:50
Auditorium VI
Jennifer Carroll
Oral presentation
Pharmacology of generic ban-evading synthetic cannabinoid receptor agonists: are new compounds spicing up the market?
13:20
to
14:50
Room 1.07
Marie Deventer
Oral presentation
Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the CAMS-2020 study
13:20
to
14:50
Room 1.07
Oral presentation
The challenge of cannabis quantification: from theory to practice
13:20
to
14:50
Room 1.07
Cláudia Sousa-Reis
Oral presentation
Reporting THC level in cannabis products: a global multidisciplinary expert consensus
13:20
to
14:50
Room 1.07
Oral presentation
Policy and Practice Responses to Drug-Related Deaths: Governance issues in English and Welsh Prisons, 2015-2021
13:20
to
14:50
Auditorium VI
Karen Duke
Oral presentation
MATPACT: An innovative approach to finding Scotland’s forgotten generation
13:20
to
14:50
Auditorium VI
Marion Gillies
Oral presentation
Smoking and nicotine use behaviours among women of reproductive age: a ten-year population study in England
13:20
to
14:50
Auditorium VIII
Sharon Cox
Oral presentation
Gender Compression Over Time in Measures of Cannabis Use by Age and Cohort in the United States
13:20
to
14:50
Auditorium VIII
Michael Vuolo
Oral presentation
The perspective of transgender and non-binary people on their substance use trajectories and resilience processes
13:20
to
14:50
Auditorium VIII
Abdelhakim Missoum
Short communication
In favor or against the codependency concept: A narrative review of arguments in scientific literature
13:20
to
14:50
Room 1.08
Alexis Beaulieu-Thibodeau
Short communication
The relationship between cannabis and tobacco use - a systematic review and meta-analysis
13:20
to
14:50
Room 1.08
Tesfa Mekonen
Short communication
Towards 2029: Learnings from unified Australian involvement in drug-related United Nations fora
13:20
to
14:50
Room 1.08
Short communication
Prevalence and trends of ethanol and drugs among arrested drivers in Norway in the period 2013-2023
13:20
to
14:50
Room 1.08
Ragnhild Jamt
Short communication
Tuning In for Chemistry: Setting up a multi-instrument mobile drug-checking lab at a 7-day psychedelic music festival
13:20
to
14:50
Room 1.08
Daniel Martins
Oral presentation
Changes in cannabis potency and cannabis-related harms: A 22-year ecological study in Denmark
13:20
to
14:50
Room 1.07
Kristine Rømer Thomsen
Oral presentation
Risk and protective factors in adolescents: adapting Communities that Care Youth Survey for Portuguese context
13:20
to
14:50
Room 5A
Susana Henriques
Short communication
Alcohol prevention: a review using Topic Modelling
13:20
to
14:50
Room 1.08
Nina Harth
Short communication
Cannabis and mental health in Germany: a baseline estimation pre legalization
13:20
to
14:50
Room 1.08
Eva-Maria Krowartz
Short communication
Evaluation of heroin-assisted treatment in Norway: Protocol for a mixed methods study
13:20
to
14:50
Room 1.08
Lars Henrik Myklebust
15:00
Oral presentation
Canada synthetic opioids situation
15:00
to
16:30
Auditorium VIII
Pam Kent
Oral presentation
Emerging drug trends – what are the issues and how can we strengthen preparedness
15:00
to
16:30
Auditorium VIII
Paul Griffiths
Oral presentation
US experience with synthetic drugs
15:00
to
16:30
Auditorium VIII
Christopher M. Jones
Oral presentation
The U.S. international perspective including the Global Coalition
15:00
to
16:30
Auditorium VIII
Charlotte Sisson
Oral presentation
How do you make it work? A pragmatic framework for the Sustained Uptake of Service Innovations (SUSI).
15:00
to
16:30
Room 1.06
Catherine Foley
Oral presentation
Evaluating and comparing health quality for addiction treatment in the Lazio region, Italy
15:00
to
16:30
Room 1.06
Antonella Camposeragna
Oral presentation
Considering the prevention workforce: a study on practitioner needs when recommending substance use interventions
15:00
to
16:30
Room 1.06
Natalie Blackburn
Oral presentation
Planning and Monitoring drug and alcohol treatment in Denmark. The MapPlan project.
15:00
to
16:30
Room 1.06
Mads Uffe Pedersen
Oral presentation
Mothers receiving substance use treatment involved in care proceedings: A record linkage cohort study
15:00
to
16:30
Room 5A
Martha Canfield
Oral presentation
Mortality among first-time opioid agonist therapy patients in Austria, 2002-2021: A national retrospective cohort study
15:00
to
16:30
Room 5A
Tanja Schwarz
Oral presentation
Drug poisoning deaths of under 30-year-olds – Key issues in the cause of death investigation documents
15:00
to
16:30
Room 5A
Sanna Rönkä
Oral presentation
Acute drug-toxicity presentations involving crack cocaine to Euro-DEN Plus sentinel hospitals in Europe from 2014-2022
15:00
to
16:30
Room 5A
Isabelle Giraudon
Oral presentation
Documenting major shifts in methamphetamine and heroin prices and purity in metropolitan and rural Victoria, Australia
15:00
to
16:30
Auditorium VI
Kasun Rathnayake
Oral presentation
Effects of recreational cannabis versus black market: A randomized controlled trial in Switzerland (WEED CARE)
15:00
to
16:30
Auditorium VI
Lavinia Baltes
Oral presentation
Drug markets and financial flows: underground banking in the Netherlands
15:00
to
16:30
Auditorium VI
Nienke Liebregts
Oral presentation
How do purity and price of cocaine affect consumption in Austria?
15:00
to
16:30
Auditorium VI
Birgit Priebe
Oral presentation
Migrants in the criminal justice system: A qualitative understanding of the role of substance use in their lives
15:00
to
16:30
Room 5C
Marjolein De Pau
Oral presentation
Drug use and (non-)use of addiction treatment by women in French Guyana: gender and migration effects
15:00
to
16:30
Room 5C
Estelle Filipe
Oral presentation
Police stops for drugs: Exploring the use of stop and search for drug offences in England
15:00
to
16:30
Room 5C
Oral presentation
Challenges and support needs among persons with a migration background who use drugs in four metropolitan cities
15:00
to
16:30
Room 5C
Wouter Vanderplasschen
Short communication
What increases the risk of problem gambling in adolescents? Findings from the Greek arm of the ESPAD study
15:00
to
16:30
Room 1.07
Alexandra Primeti
Short communication
Financial hardship and gambling severity: a population-based study in Finland
15:00
to
16:30
Room 1.07
Tanja Grönroos
Short communication
Harmful types of gambling: Changes and emerging trends in longitudinal helpline data
15:00
to
16:30
Room 1.07
Håkan Wall
Short communication
Accessibility, local socioeconomic disadvantage and expenditure on electronic gambling machines
15:00
to
16:30
Room 1.07
Jani Selin
Short communication
Extended hours of video game play and negative physical symptoms and pain
15:00
to
16:30
Room 1.07
Janni Leung
Short communication
Prevention is key: A case of a gambling prevention program among Portuguese high-school students
15:00
to
16:30
Room 1.07
Short communication
Religiosity and gambling - moderating role of reflective thinking: A Polish-Georgian Study
15:00
to
16:30
Room 1.07
Rafał Bartczuk
Oral presentation
Psychoactive Substance Use Among Russian Migrants Relocated to Georgia Following the 2022 Ukrainian Invasion
15:00
to
16:30
Room 5C
David Otiashvili
Oral presentation
Refugees & drug use in Belgium: A national study on drug-related intervention needs in the reception setting (DrugInt)
15:00
to
16:30
Room 5C
Charlotte de Kock
Short communication
Online Gambling Companies’ Interpretation of Duty of Care and its Implication for Responsibilisation of Gambling Related Harm
15:00
to
16:30
Room 1.07
Maria Persson
16:50
Keynote presentation
The increase of 100% alcohol-attributable mortality in the EU during COVID-19 – implications for the health care system
16:50
to
18:20
Auditorium I
Jürgen Rehm
Keynote presentation
The EAR-EUFAS European Addiction Research Award 2024 - presentation of the award and the awardee
16:50
to
18:20
Auditorium I
Karen Ersche,
Colin Drummond
Keynote presentation
Andreas Heinz’ award lecture: Learning mechanisms in addictive disorders
16:50
to
18:20
Auditorium I
Andreas Heinz
Short communication
Improving the model of care pathway for HCV between the drug care centres and their referral hospitals in Catalonia.
16:50
to
18:20
Room 1.05
Elena Torrell -Pedreira
Short communication
STTBI risk reduction with OAT among people with prescription-type opioid use disorder
16:50
to
18:20
Room 1.05
M. Eugenia Socias
Short communication
Are Australian pharmacists willing and prepared to offer Hepatitis C services? Findings from a representative sample
16:50
to
18:20
Room 1.05
Louisa Picco
Short communication
Looking under rocks: Skin infections in people who use drugs: a mixed-methods investigation in Wales
16:50
to
18:20
Room 1.05
Michelle Hughes
Short communication
HCV antibody and RNA testing combined with nursing and peer-based outreach to enhance HCV testing and treatment among vulnerable groups
16:50
to
18:20
Room 1.05
Solange Mendes Ascensão
Short communication
Prevalence and microelimination of Hepatitic C in intravenous drug users - improving linkage to care
16:50
to
18:20
Room 1.05
Eva-Carina Heier
Oral presentation
Assessing quality of substance use treatment in legal settings: lessons from United States drug courts
16:50
to
18:20
Auditorium VI
Steven Belenko
Oral presentation
Quantifying and expanding alternatives to arrest for use and possession offences for illicit drugs
16:50
to
18:20
Auditorium VI
Caitlin Hughes
Oral presentation
Law Enforcement Encounters and Decriminalization Gaps: Insights from People Who Use Drugs in Oregon Post-Measure 110
16:50
to
18:20
Auditorium VI
Morgan Godvin
Oral presentation
Achieving universal health coverage of opioid agonist treatment in Norway: a cost-utility analysis
16:50
to
18:20
Room 5B
Prayash Chaudhary
Oral presentation
Route-Dependent Subjective Effects of Medical Heroin in HAT: Implications for Treatment Trajectories
16:50
to
18:20
Room 5B
Silvana De Pirro
Oral presentation
AN IMPLEMENTATION SCIENCE EVALUATION OF SCOTLAND’S FIRST HEROIN ASSISTED TREATMENT (HAT) FACILITY
16:50
to
18:20
Room 5B
Andrew McAuley
Oral presentation
Reduced health care utilization after entering opioid agonist treatment; change in mental and somatic health domains
16:50
to
18:20
Room 5B
Thomas Clausen
Oral presentation
The U.S. Psilocybin Landscape: Policy Evolution and Nationally Representative Insights
16:50
to
18:20
Auditorium VIII
Beau Kilmer
Oral presentation
Self-therapeutic use of psilocybin, MDMA and ketamine among Dutch nightlife attendees.
16:50
to
18:20
Auditorium VIII
Frederiek Schutten
Oral presentation
Medical use of psychedelic substances: EUDA's monitoring of key developments
16:50
to
18:20
Auditorium VIII
Alexander Söderholm
Oral presentation
Navigating Psychedelic Therapy for Addiction: Past, Present, and Future
16:50
to
18:20
Auditorium VIII
Short communication
Oxycodone and Morphine use in hospitals and primary healthcare in Norway 2010-2021
16:50
to
18:20
Room 1.06
Eirik Haarr
Short communication
Global utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder
16:50
to
18:20
Room 1.06
Michael Frost
Short communication
Trends in the detection and co-detection of drugs in a population attending opioid agonist treatment: 2010 to 2020
16:50
to
18:20
Room 1.06
Gráinne Cousins
Short communication
Being Seen and Heard: Exploring the Relational Dimension of Heroin Assisted Treatment in Norway.
16:50
to
18:20
Room 1.06
Vegard Haukland
Short communication
Death after residential treatment for opioid use disorder among people using fentanyl
16:50
to
18:20
Room 1.06
Jan Gryczynski
Oral presentation
(De)criminalisation of drug possession as a litmus test of national drug policy? Experience from the Czech Republic
16:50
to
18:20
Auditorium VI
Petr Zeman
Short communication
Mortality among long-term prescription opioid users
16:50
to
18:20
Room 1.06
Gabriela Rolová
Short communication
Adão e Eva II Project – HIV, Hepatitis and other STI’s prevention and screening among hard-to-reach populations
16:50
to
18:20
Room 1.05
Paulo Anjos
Oral presentation
Police drug diversion in England and Wales: Findings from a realist process evaluation
16:50
to
18:20
Auditorium VI
Alex Beerjeraz
18:30
Discussion
Why are we not doing better at reducing drug-related deaths?
18:30
to
19:30
Auditorium I
Thomas Clausen,
Marie Jauffret-Roustide,
Keith Humphreys,
Paul Dietze,
Katri Abel-Ollo
Thursday, 24 October
10:50
Keynote presentation
International Collaboration on ADHD and Substance Abuse (ICASA): Mission, studies, results, and plans
10:50
to
12:20
Auditorium I
Wim van der Brink
Keynote presentation
International Collaboration on ADHD and Substance Abuse: Consensus statements
10:50
to
12:20
Auditorium I
Cleo Crunelle
Keynote presentation
Identifying the most important research, policy and practice questions for substance use, problematic alcohol use and behavioural addictions in autism (SABA-A): A priority setting partnership
10:50
to
12:20
Auditorium I
Julia Sinclair
Short communication
Definition of public amenity in drug consumption room literature: A scoping review
10:50
to
12:20
Auditorium VII
Bianca Whiteside
Short communication
Enhancing Harm Reduction: A Qualitative Evaluation of Athens' Drug Consumption Room
10:50
to
12:20
Auditorium VII
Benjamin Scher
Short communication
The Value of Peer Research: A Peer Perspective
10:50
to
12:20
Auditorium VII
Christos Anastasiou
Short communication
Reasons for (non-)using a drug consumption room: the point of view of drug users.
10:50
to
12:20
Auditorium VII
Sanda Samitca
Short communication
Safe Inhalation Pipe Provision Study: Intervening to improve policy and practice for people who use crack in England.
10:50
to
12:20
Auditorium VII
Magdalena Harris
Short communication
A scoping review of mass media interventions intended to reduce stigma towards people who use drugs
10:50
to
12:20
Auditorium VII
Adam Holland
Short communication
Overdoses in the drug consumption room in Oslo: route of administration matters!
10:50
to
12:20
Auditorium VII
Desiree Eide
Short communication
Changes in the use of non-prescribed hydromorphone and unregulated opioids use in Vancouver, Canada, 2018-2022
10:50
to
12:20
Auditorium VII
Kanna Hayashi
Oral presentation
Perceptions of family physicians in Istanbul on e-cigarettes as smoking cessation aids
10:50
to
12:20
Room 1.08
Melis Selamoglu
Oral presentation
Key challenges for alcohol epidemiology and alcohol control policy evaluation
10:50
to
12:20
Auditorium VI
Jürgen Rehm
Oral presentation
Legally grey? Drug checking perspectives in the CEECA region
10:50
to
12:20
Auditorium VI
Eliza Kurcevič
Oral presentation
Public health for whom? Unpacking the assumptions and silences in Canada's public health approach to substance use.
10:50
to
12:20
Auditorium VI
Sophie Henderson
Oral presentation
The Costs and Harms of Substance Use in Canada: Key Trends from 2007 to 2022
10:50
to
12:20
Auditorium VI
Pam Kent
Oral presentation
Cannabis policy and practice in Finland: from social media discussions to citizens initiatives
10:50
to
12:20
Room 1.08
Aleksi Hupli
Oral presentation
A Holistic Multi-Disciplinary Healthcare Pathway for Older Men who use Anabolic Androgenic Steroids
10:50
to
12:20
Room 1.08
Evelyn Hearne
Oral presentation
Drugs and climate change: knowledge gaps in monitoring environmental impacts of drugs
10:50
to
12:20
Room 1.08
Tim Surmont
Oral presentation
A wastewater-based approach to monitor shifting trends in illicit drugs consumption in Switzerland
10:50
to
12:20
Room 5A
Livia Andrani
Oral presentation
What can Portugal do to prevent be caught off guard again in the drug domain?
10:50
to
12:20
Room 5A
Alcina Correia
Oral presentation
European Hair Drug Analisys Network – A pioneer study to investigate the use of NPS and NSO
10:50
to
12:20
Room 5A
Elisa Fornero
Oral presentation
Synthesis of multisource data for the development of an advanced dashboard to monitor illicit drugs markets
10:50
to
12:20
Room 5A
Pierre Esseiva
13:20
Short communication
Empowering Global Drug Prevention: A Systematic Approach
13:20
to
14:50
Room 1.06
Ali Yassine
Short communication
Making a case for health promotion theoretically underpinned policies and practices around alcohol in workplace settings
13:20
to
14:50
Room 1.06
Lolita Alfred
Short communication
Introducing the European Prevention Curriculum (EUPC) in Austria – findings from a pilot implementation
13:20
to
14:50
Room 1.06
Martin Busch
Short communication
Advancing Science-Based Prevention: Insights from the EUPC Training in Bosnia and Herzegovina
13:20
to
14:50
Room 1.06
Amir Hasanovic
Short communication
Piloting EUPC Training in the Republic of Georgia: Lessons Learned
13:20
to
14:50
Room 1.06
Jana D. Javakhishvili
Short communication
TRAINING ON THE EUROPEAN PREVENTION CURRICULUM (EUPC) FOR DOPs- THE CYPRIOT EXPERIENCE
13:20
to
14:50
Room 1.06
Maria Matheou
Keynote presentation
Policy approaches in behavioral addictions: past experiences and possible Future Directions
13:20
to
14:50
Auditorium I
Orsolya Király
Oral presentation
Overview of the Cannabis Act and Cannabis Regulations
13:20
to
14:50
Room 5A
Robert Gabrys
Short communication
The Frontine Politeia project: the need for involving prevention implementers within substance use and crime prevention
13:20
to
14:50
Room 1.06
Annemie Coone
Keynote presentation
Recovery from Behavioral Addictions: Concepts, Unique Challenges and Issues
13:20
to
14:50
Auditorium I
Belle Gavriel-Fried
Oral presentation
A Review of the Public Health and Safety Impacts of Cannabis of Legalization and Key Recommendations
13:20
to
14:50
Room 5A
Justine Renard
Short communication
Strengthening the capacity and agency of drug prevention stakeholders on the key issue of evidence-based prevention.
13:20
to
14:50
Room 1.06
Rachele Donini
Keynote presentation
Treatment of Behavioural Addictions: Where are we now?
13:20
to
14:50
Auditorium I
Klaus Wölfling
Oral presentation
Looking Ahead: Future Priorities for Cannabis Research, Public Education, and Prevention
13:20
to
14:50
Room 5A
Shea Wood
Oral presentation
Drug-related deaths among housed and homeless individuals in the UK and the USA
13:20
to
14:50
Auditorium IV
Emmert Roberts
Oral presentation
Drug-related mortality associated with gabapentinoid/Z-drug co-prescribing among opioid-agonist treatment recipients
13:20
to
14:50
Auditorium IV
Megan Glancy
Oral presentation
Policy Responses to Drug-Related Deaths: The power of numbers?
13:20
to
14:50
Auditorium IV
Lena Eriksson
Oral presentation
High body mass index is prevalent in people with opioid use disorder in Northern England and increases risk of death
13:20
to
14:50
Auditorium IV
Caroline Copeland
Oral presentation
International drug policy constellations: exploring the role of power and morality in international drug policy debates
13:20
to
14:50
Auditorium VI
Alex Stevens
Oral presentation
Conceptualising the right to health in the context of the world drug problem
13:20
to
14:50
Auditorium VI
Alison Ritter
Oral presentation
Squandered sexenio: applying drug policy constellations to the failure of marijuana legalization in Mexico (2018-2024)
13:20
to
14:50
Auditorium VI
Jonas von Hoffmann
Oral presentation
Policy responses to drug-related deaths: Using a Social Determinants of Health framework analysis to inform policy
13:20
to
14:50
Auditorium VI
Aileen O'Gorman
Oral presentation
Vulnerabilities and agencies of women who use and sell drugs in Bordeaux and Montréal
13:20
to
14:50
Room 1.08
Sarah Perrin
Oral presentation
Unveiling the Nexus of Addiction, Violence, and Risk: Generational Patterns in Female Populations
13:20
to
14:50
Room 1.08
Sabrina Molinaro
Oral presentation
Female-specific trends and treatment needs for substance use disorder among homeless and at-risk females
13:20
to
14:50
Room 1.08
Anne Marie Carew
Oral presentation
Gender and drugs: Experiences of stigma/toxicophobia and narcofeminist narratives
13:20
to
14:50
Room 1.08
Marie Jauffret-Roustide
15:00
Oral presentation
Evaluating the progress of alcohol policies in Burundi against the WHO ‘best buy’ interventions.
15:00
to
16:30
Auditorium II
Oral presentation
The case of Kratom: from traditional medical to recreational use
15:00
to
16:30
Room 1.05
Vicknasingam Balasingam
Oral presentation
Socioeconomic differences in the real-world effectiveness of pharmacotherapy of alcohol-related health problems
15:00
to
16:30
Auditorium II
Devy Elling
Oral presentation
Exploring Novel Psychoactive Substances Among Kazakhstan's Youth: A Focus on Emerging Trends and Risks
15:00
to
16:30
Room 1.05
Mariya Prilutskaya
Oral presentation
Estimating the global burden of alcohol's harm to others
15:00
to
16:30
Auditorium II
Anne-Marie Laslett
Oral presentation
Emerging Drug trends in Japan: rethinking prevention strategies
15:00
to
16:30
Room 1.05
Hironobu Fujiwara
Oral presentation
Economic wealth, patterns of drinking, and alcohol-attributable disease burden
15:00
to
16:30
Auditorium II
Pol Rovira
Oral presentation
Experiences of building a Prompt Response Network for emerging drugs of concern in Australia
15:00
to
16:30
Room 1.05
Brendan Clifford
Oral presentation
Modelling the impact of scaling up of HCV case finding and treatment for people who inject drugs in England
15:00
to
16:30
Auditorium IV
Zoe Ward
Oral presentation
A national program to scale-up decentralized HCV point-of-care testing and treatment in Australia
15:00
to
16:30
Auditorium IV
Jason Grebely
Oral presentation
HCV Community-led monitoring: from consultation to effective policy contributions
15:00
to
16:30
Auditorium IV
Lynn Jefferys,
Joana Canedo
Oral presentation
Pilot HCV Birth Cohort Screening in UK Primary Care using a postal oral fluid home testing kit: the HEPCAPP StudyPP STUDY
15:00
to
16:30
Auditorium IV
Matt Hickman
Oral presentation
Online Addictions Expert Group of the Pompidou Group: Results and Recommendations
15:00
to
16:30
Room 5B
Jann Schumacher
Oral presentation
The end of responsible gambling
15:00
to
16:30
Room 5B
Charles Livingstone
Oral presentation
Prevention when exclusion is lifted: Intervention models from the New Swiss Gambling Act
15:00
to
16:30
Room 5B
Linda Elezi
Oral presentation
A provisional evaluation of Australia’s medical cannabis framework
15:00
to
16:30
Auditorium VI
Myfanwy Graham
Oral presentation
Consequences of cannabis legalization on use and health outcomes on the basis of international experiences
15:00
to
16:30
Auditorium VI
Uwe Verthein
Oral presentation
A comparative analysis of state-controlled models for legal cannabis sales in Uruguay and Quebec (Canada)
15:00
to
16:30
Auditorium VI
Marta Rychert
Oral presentation
Same Intentions, Different Outcomes: Divergent Paths and Implementation Gaps in Cannabis Legalization in North America
15:00
to
16:30
Auditorium VI
Ivana Obradovic
Oral presentation
LECUCA: Analysis of Brazil's largest open drug scene using time-series cross-sectional survey data
15:00
to
16:30
Room 1.08
Clarice Madruga
Oral presentation
25 years of monitoring the Dutch cannabis market using chemical analys: trends, developments and technical discussion
15:00
to
16:30
Room 1.08
Pieter Oomen
Oral presentation
Drug monitoring by samples seized at 2018, 2022 and 2023 BOOM festival editions
15:00
to
16:30
Room 1.08
Carla Filipa Ferreira
Oral presentation
Trends in illicit and licit substance use across Spain – A comprehensive three-year wastewater-based epidemiology study.
15:00
to
16:30
Room 1.08
José Benito Quintana
Oral presentation
Risks and harms associated with online gaming and gambling
15:00
to
16:30
Room 5B
Eduarda Ferreira
16:50
Discussion
How can the voices of people with lived experience, clients and communities impacted by drug use better inform clinical practice, research and the policy agenda?
16:50
to
17:50
Auditorium I
Tony Duffin,
Luís Mendão,
Joanne Neale,
Elizabeth (Elza) Berk,
Judy Chang
Short communication
Metabolite profile of synthetic cannabinoids seized in Portugal
16:50
to
18:20
Room 1.06
Rita Padinha Lopes
Oral presentation
Pushing the limits of tobacco control; How far can the state go in order to save us from our 'sins'?
16:50
to
18:20
Room 5A
Karl Erik Lund
Oral presentation
Cannabis liberalization is only associated with increased blunt use if states lack strong tobacco control
16:50
to
18:20
Room 5A
Brian Kelly
Oral presentation
The impact of alcohol taxation on alcohol-attributable health inequalities in the US: a microsimulation study
16:50
to
18:20
Room 5A
Carolin Kilian
Oral presentation
Do minimum unit pricing policies reduce alcohol harms? A review of new evidence.
16:50
to
18:20
Room 5A
Cassandra Wright
Short communication
Diversion to treatment of drug related offenders at the sentencing stage. A quantitative & qualitative analysis
16:50
to
18:20
Room 1.06
Natasa Savvopoulou
Short communication
The experience of aging among patients in opioid assisted treatment. A qualitative study.
16:50
to
18:20
Room 1.06
Siv-Elin Leirvåg Carlsen
Short communication
A comparison of sales regulations across three types of cannabis dispensaries: First insights from the 'Züri Can' study
16:50
to
18:20
Room 1.06
Nadine Heckel
Short communication
Cannabis users and strain expectancies: A contextual investigation of cannabis strain availability in illicit markets
16:50
to
18:20
Room 1.06
Short communication
Managing the drug-driver: insights from Victoria’s large-scale roadside testing program
16:50
to
18:20
Room 1.06
Michael Fitzharris
Oral presentation
Understanding Drug Use in a Dutch Prison: A Call for Improved Research and Care and Lessons learned
16:50
to
18:20
Auditorium III
Daan van der Gouwe
Oral presentation
New challenges for outpatient care: trends from twenty years of monitoring treatment demand in the city of Hamburg
16:50
to
18:20
Room 5C
Marcus Martens
Oral presentation
It is time to take nitrous oxide seriously
16:50
to
18:20
Room 5C
Julaine Allan
Oral presentation
Nangs in Australia: Investigating nitrous oxide use among people who regularly use MDMA and/or other illicit stimulants
16:50
to
18:20
Room 5C
Jodie Grigg
Oral presentation
Population aging and apparent decline in initiation of injecting drug use in Australia
16:50
to
18:20
Room 5C
Olivia Price
Oral presentation
Cocaine use on the rise – are politicians and city level services prepared for the emerging trend of crack cocaine?
16:50
to
18:20
Auditorium III
Else Kristin Utne Berg
Oral presentation
Words vs. strands: Does the concordance of self-reported and hair-analyzed substance use of young adults change over time?
16:50
to
18:20
Auditorium III
Clarissa Janousch
Short communication
The impact of Cannabis market Regulation on adolescents in Uruguay
16:50
to
18:20
Room 1.06
Leticia Keuroglian
Short communication
Recommendations from the government cannabis committee on the legal availability of vaping products.
16:50
to
18:20
Room 1.06
Robert Perreault
Oral presentation
Responding to the identification of nitazenes within the illicit diazepam market
16:50
to
18:20
Auditorium III
Josie Smith
Friday, 25 October
10:50
Oral presentation
Predictors of untreated remission of Internet Use Disorder in a sample of adolescents and young adults
10:50
to
12:20
Auditorium III
Lasse Schmidt
Oral presentation
Illegal loot box advertising on social media: an empirical study using the Meta and TikTok ad transparency repositories
10:50
to
12:20
Auditorium III
Leon Y. Xiao
Oral presentation
Development and validation of the Problematic Dating App Use Scale (PRODAS): First results from a sexual minority cohort
10:50
to
12:20
Auditorium III
Babette Lea Winter
Oral presentation
Relationship between parenting styles and problematic Internet use
10:50
to
12:20
Auditorium III
Antonio Raya
Short communication
The Unique Public Health Threat of Counterfeit Pills with Synthetic Drugs: What Can Europe Learn From America's Mess?
10:50
to
12:20
Room 1.05
Short communication
An action plan for synthetic opioids - The Zurich approach
10:50
to
12:20
Room 1.05
Dominique Schori
Short communication
Gabapentinoids in Ireland (2010-2020): trends in prescribing, law enforcement drug seizures & post-mortem toxicology
10:50
to
12:20
Room 1.05
Gráinne Cousins
Short communication
The emergence of nitazenes on the Irish heroin market: Lessons learned and challenges moving forward
10:50
to
12:20
Room 1.05
Nicki Killeen
Short communication
New research unit provides evidence to address national addictions policy challenges
10:50
to
12:20
Room 1.05
Leonie Brose
Short communication
Community attitudes towards sanction and health-based interventions for individuals caught drug-driving in Australia
10:50
to
12:20
Room 1.05
Sara Liu
Short communication
Increasing availability and production of synthetic cathinones in Europe – a perspective from the EU EWS
10:50
to
12:20
Room 1.05
Gregorio Planchuelo
Short communication
Drugsinfo.nl, a public health interventions new approach for rapid response to trends in the Dutch drugs market
10:50
to
12:20
Room 1.05
Short communication
MDMA misinformation: what dealers claim versus the actual MDMA content in ecstasy pills in the netherlands
10:50
to
12:20
Room 1.05
Lavinia Stegemann
Short communication
Development of an evidence-based classification framework for psychoactive substances in the illicit drug market
10:50
to
12:20
Room 1.05
Michèle Boileau-Falardeau
13:20
Oral presentation
Work related cocaine use: prevalence and interventions
13:20
to
14:50
Auditorium II
Marie-Claire Lambrechts
Oral presentation
Controlled cannabis supply chain experiment: state of affairs and lessons learned
13:20
to
14:50
Auditorium VIII
Margriet Van Laar
Oral presentation
The Workplace as a “Co-Therapist”
13:20
to
14:50
Auditorium II
Camilla Lynne Bakkeng
Oral presentation
Cannabis law reform in Switzerland: purpose, opportunities, and risks of local pilot projects
13:20
to
14:50
Auditorium VIII
Frank Zobel
Oral presentation
Issues of transport, driving safety & intoxication for opioid agonist treatment clients in New South Wales, Australia
13:20
to
14:50
Auditorium VI
Daniel Winter
Oral presentation
Individual agreements for recovery from substance misuse. Employees’ response and experience of regulatory aspects.
13:20
to
14:50
Auditorium II
Marianne Lund
Oral presentation
Cannabis law reform in Luxembourg: first observations after its change among recreational cannabis users and non-users
13:20
to
14:50
Auditorium VIII
Nadine Berndt
Oral presentation
Physical conditions and associated health service utilization among individuals with substance-related disorders
13:20
to
14:50
Auditorium VI
Christophe Huỳnh
Oral presentation
A healthy work environment for Eastern European migrant workers in The Netherlands
13:20
to
14:50
Auditorium II
Desirée Spronk
Oral presentation
The effect of substance use disorders on vaccine uptake, acceptance, and adherence: a global systematic review
13:20
to
14:50
Auditorium VI
Eva Maria Havelka
Oral presentation
Pathways into individual substance misuse recovery agreement in the workplace
13:20
to
14:50
Auditorium II
Janne Scheffels
Oral presentation
Cannabis law reform in Germany: a rocky road to a partial legalisation
13:20
to
14:50
Auditorium VIII
Jakob Manthey
Oral presentation
Out of treatment drug and alcohol users in England: ‘Unmet Treatment Need’?
13:20
to
14:50
Auditorium VI
Charlie Lloyd
Oral presentation
The impacts of cannabis legalization in the Americas: Insights from a systematic review
13:20
to
14:50
Room 5B
Elle Wadsworth
Oral presentation
Spatial analysis of drug seizure events in the Golden Triangle: Findings from UNODC’s Drug Monitoring Platform
13:20
to
14:50
Room 5B
Bryce Pardo
Oral presentation
Impact of Precursor Control on Drug Markets: An Expanded and Updated Systematic Review
13:20
to
14:50
Room 5B
Luca Giommoni
Oral presentation
The impact of the 2022 ban on drug production in Afghanistan
13:20
to
14:50
Room 5B
Angela Me
Oral presentation
Assessing and managing cognitive deficit as a comorbidity in drug addiction
13:20
to
14:50
Auditorium VI
Oral presentation
Drug an ALcohol Related Intoxication Among Young Adolecents in Palestine
13:20
to
14:50
Auditorium III
Saed Bilbaisi
Oral presentation
New processes of normalisation? Understanding changes in young people's drug use in the UK.
13:20
to
14:50
Auditorium III
Harry Sumnall
Oral presentation
Does Variation in Local Policy Mediate the Impact of Legal Cannabis Markets on Adolescent Cannabis Use?
13:20
to
14:50
Auditorium III
Rosalie Liccardo Pacula
Oral presentation
The (cost-)effectiveness of contingency management for cannabis use disorder in youth: A randomized controlled trial
13:20
to
14:50
Auditorium III
Eva Garssen